Nosocomial MRSA pneumonia: data from recent clinical trials.
Rev Recent Clin Trials
; 6(3): 235-40, 2011 Sep.
Article
en En
| MEDLINE
| ID: mdl-21682676
ABSTRACT
MRSA infections, especially pneumonia have been associated with considerable morbidity and mortality and the management of MRSA infections is considered as an issue of high priority for scientific societies. Many studies which have been published during the last 10 years have provided evidence for MRSA pneumonia epidemiology, diagnosis and treatment. The main regime of antibiotic treatment recommended for MRSA pneumonia is either vancomycin or linezolid. Despite its pK/pD superiority over vancomycin, linezolid has to date failed to show clear advantage over vancomycin in recent clinical trials.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Neumonía Estafilocócica
/
Infección Hospitalaria
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Rev Recent Clin Trials
Asunto de la revista:
MEDICINA
/
TERAPEUTICA
Año:
2011
Tipo del documento:
Article
País de afiliación:
Grecia